Viewing Study NCT04958993


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2025-12-25 @ 11:26 PM
Study NCT ID: NCT04958993
Status: TERMINATED
Last Update Posted: 2022-02-25
First Post: 2020-08-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer
Sponsor: Shandong Cancer Hospital and Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module